Skip to main content

Animations

MJFF Publications

1351 - 1360 of 6514 Results
Title
Year
  • Year
  • 2011
  • 2019
  • 2020
  • 2025
  • 2017
  • 2021
  • 2022
  • 2016
  • 2018
  • 2018
  • Summary Details
    OPEN
    Title: Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.031
    Citation Count: 56
  • Summary Details
    OPEN
    Title: An estimate of the total number of true human miRNAs
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/nar/gkz097
    Citation Count: 494
  • Summary Details
    OPEN
    Title: Three-Plane–assembled Deep Learning Segmentation of Gliomas
    Journal Name: Radiology: Artificial Intelligence
    Publisher: Radiological Society of North America (RSNA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1148/ryai.2020190011
    Citation Count: 24
  • Summary Details
    OPEN
    Title: A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-025-00889-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: RIC3 variants are not associated with Parkinson's disease in French-Canadians and French
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.01.005
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.28525
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Nicotine‐Mediated Rescue of α‐Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in Drosophila
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29283
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23192
    Citation Count: 78
  • Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration
    2018
    Summary Details
    OPEN
    Title: Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddy308
    Citation Count: 30
  • Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    2018
    Summary Details
    OPEN
    Title: Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27392
    Citation Count: 139
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.